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ABSTRACT
Background Hereditary short stature syndromes are
clinically and genetically heterogeneous disorders and the
causehavenotbeenfullyidentiﬁed.Yakutsareapopulation
isolated in Asia; they live in the far east of the Russian
Federation and have a high prevalence of hereditary short
stature syndrome including 3-M syndrome. A novel short
stature syndrome in Yakuts is reported here, which is
characterised by autosomal recessive inheritance, severe
postnatal growth retardation, facial dysmorphism with
senile face, small hands and feet, normal intelligence,
Pelger-Hue ¨t anomaly of leucocytes, and optic atrophy with
lossofvisualacuityandcolourvision.Thisnewsyndromeis
designated as short stature with optic atrophy and Pelger-
Hue ¨t anomaly (SOPH) syndrome.
Aims To identify a causative gene for SOPH syndrome.
Methods Genomewide homozygosity mapping was
conducted in 33 patients in 30 families.
Results The disease locus was mapped to the 1.1 Mb
region on chromosome 2p24.3, including the
neuroblastoma ampliﬁed sequence (NBAS) gene.
Subsequently, 33 of 34 patients were identiﬁed with SOPH
syndrome and had a 5741G/A nucleotide substitution
(resulting in the amino acid substitution R1914H) in the
NBAS gene in the homozygous state. None of the 203
normal Yakuts individuals had this substitution in the
homozygousstate.Immunohistochemicalanalysisrevealed
that the NBAS protein is well expressed in retinal ganglion
cells, epidermal skin cells, and leucocyte cytoplasm in
controls as well as a patient with SOPH syndrome.
Conclusion These ﬁndings suggest that function of NBAS
may associate with the pathogenesis of short stature
syndrome as well as optic atrophy and Pelger-Hue ¨t
anomaly.
INTRODUCTION
Hereditary short stature syndromes are clinically
and genetically heterogeneous disorders charac-
terised by growth retardation with characteristic
dysmorphism in the face and body. Although the
various genes have been identiﬁed as being causa-
tive for hereditary short status syndrome, many
cases are not explained. Yakuts are a population
isolate in Asian and live in the northeastern part of
Siberia in the Republic of Sakha of the Russian
Federation.
1 2 They exhibit high frequencies of
some hereditary disorders.
3 Among them short
stature syndrome, a rare recessive inherited disease
in other populations, is the major hereditary
disease.
4 There are two types of short stature
syndrome in Yakuts. We applied the homozygosity
mapping approach and subsequently identiﬁed an
identical mutation in the Cullin 7 (CUL7) gene in
all 43 Yakut patients with the short stature
syndrome, indicating that Yakuts have a founder
chromosomeresponsiblefortheCUL7mutation.
125
TheCUL7genehasbeenidentiﬁedasacausativegene
for 3-M syndrome (MIM 273750), which is a rare
autosomal recessive disorder characterised by severe
pre- and postnatal growth retardation and facial
dysmorphism but with normal intelligence.
267The
prevalencerateofshortstaturesyndromewithCUL7
mutation in Yakuts is approximately 0.01% (at least
43 patients among 440000 people), whereas only
fewer than 60 patients with 3-M syndrome have
been reported thus far.
7e15 This result conﬁrms that
Yakuts are a population isolate. The other type of
short stature syndrome in Yakuts is an autosomal
recessive postnatal growth failure, normal intelli-
gence,lossofvisualacuity,andPelgereHuëtanomaly
(PAH), which is characterised by an abnormal
nuclear shape in neutrophil granulocytes (MIM
169400). In this study, we mapped the disease locus
forthisnewtypeofshortstaturesyndrometo2p24.3
and identiﬁed an identical missense mutation in the
neuroblastoma ampliﬁed sequence (NBAS) gene in
patients with this syndrome.
PATIENTS AND METHODS
Patients and control samples
In the regional Department of Medical Genetical
Consultation of the Republican Hospital No.
1-National Medical Centre in Yakutsk (Russia), we
enrolled patients from 31 Yakut families who
fulﬁlled the following clinical criteria: short stature,
autosomal recessive inheritance, and optic nerve
atrophy. To exclude the possibility that they had
mutations in CUL7, which results in Yakut short
status syndrome, we sequenced the coding region in
CUL7 and found no nucleotide substitution.
Ophthalmological examination was performed by
paediatric ophthalmologists. Affected siblings were
recruited from three families. We retrospectively
reviewed the medical records of these patients. Birth
< Supplementary tables are
published online only. To view
these ﬁles please visit the
journal online (http://jmg.bmj.
com).
For numbered afﬁliations see
end of article.
Correspondence to
Dr Osamu Onodera, Department
of Molecular Neuroscience,
Resource Branch for Brain
Disease, Brain Research
Institute, Niigata University,
1-757 Asahimachi, Niigata
951-8520, Japan;
onodera@bri.niigata-u.ac.jp
NM and KH contributed equally
to this work.
Accepted 26 January 2010
Published Online First
24 June 2010
This paper is freely available
online under the BMJ Journals
unlocked scheme, see http://
jmg.bmj.com/site/about/
unlocked.xhtml
538 J Med Genet 2010;47:538e548. doi:10.1136/jmg.2009.074815
Original articlesize and subsequent lengths/heights were expressed as standard
deviation scores (SDS) according to the Yakut standards. For
analysis of PHA, we calculated the average lobe index (ALI) of the
neutrophils using the following formula: the total number of
nuclear lobes in 100 neutrophils divided by 100.
16 We used 203
DNA samples from healthy Yakut individuals as normal controls.
Genomic DNA was extracted from peripheral blood leucocytes
according to a standard protocol. Blood samples were obtained
after patients gave informed consent. The study was approved by
the institutional review board of Niigata University.
Genome wide homozygosity mapping
We performed genome wide homozygosity mapping of the 33
affected individuals using 811 microsatellite markers (ABI
PRISM Linkage Mapping Set HD-5; Applied Biosystems, Foster
City, California, USA) covering the entire autosome with an
average interval of 4.6 cM. We carried out polymerase chain
reaction (PCR) using various MapPair microsatellite markers and
analysed the PCR products using an ABI Prism 3100 genetic
analyser (Applied Biosystems). We determined all allele sizes
using the GeneScan (version 3.1.2; Applied Biosystems) and
GENEMAPPER programs (Applied Biosystems). The genetic
distance between adjacent markers was determined with the
Marshﬁeld sex averaged linkage map.
Fine homozygosity mapping in the candidate region
To narrow the candidate region, three dinucleotide polymorphic
markers, M1491, M1542, and M1599 between D2S219 and
D2S2295, were developed on the basis of simple repeat infor-
mation from the UCSC Genome Browser on Human dated May
2004 (http://genome.ucsc.edu/index.html). The positions of
chromosome 2 on each marker are 14913070 bp, 15429187 bp,
and 15991354 bp, respectively. The following primer
pairs were designed for these new markers: M1491 (forward
primer, 59- AGTTTTGCTAACCTGGAAGTC-39 and reverse
primer, 59- ctgtgttccatcttctatgtg-39); M1542 (forward primer, 59-
CATGTGCACTCACATGAATAC -39 and reverse primer, 59-
CTGGCCAGTATACCTAATTTG-39); and M1599 (forward
primer, 59- AATCCAAGGTCTGAGAGCAG-39 and reverse
primer, 59-GCAGTGGACATCATCCAATC-39). PCR reactions
consisted of an initial denaturation step of 3 min at 958C,
ampliﬁcation with denaturation for 30 cycles of 1 min at 958C,
annealing for 1 min at 558C, and extension for 1 min at
728C, followed by a ﬁnal extension step for 10 min at 728C. The
allele frequencies of each marker were determined by analysing
50 Yakut control subjects.
Mutational analyses of DDX1 and NBAS genes
A series of 24 intronic primers for amplifying the 26 coding
exons of DDX1 and a series of 52 intronic primers for 52 coding
exons of NBAS were designed (see supplementary table). Each
exon was ampliﬁed by PCR and the ampliﬁed products
were puriﬁed with ExoSAP-IT (Amersham-Bioscience, Sunny-
vale, California, USA) to a cycle sequence reaction with the
use of BigDye Terminator version 3.0 (Applied Biosystems). We
puriﬁed the reaction products using a NucleoSEQ kit (Macherey-
Nagel, Düren, Germany) and analysed the products using an ABI
3100 DNA sequencer (Applied Biosystems). PolyPhen (http://
genetics.bwh.harvard.edu/pph/) was used to predict the effect
of the substitutions.
17
Immunohistochemical analysis
Normal human tissue slides were obtained from US Biomax
(Rockville, MD), Inc. Anti-NBAS mouse polyclonal antibody
(Abnova Corporation, Taipei, Taiwan) was used for immunos-
taining. To assess the expression style of the antigen of the neuro-
blastoma ampliﬁed sequence (NBAS) in normal humans, we
prepared formalin ﬁxed, parafﬁn embedded sections of eye (82-year-
old woman, 58-year-old man, 1-year-old girl, and 1-year-old boy),
brain tissue (73-year-old woman), and skin (50-year-old woman).
Peripheral blood smears were ﬁxed at 20% formalin. Eye and brain
tissue sections were pretreated with heat retrieval in a microwave
oven for 30 min in 10 mM sodium citrate buffer (pH 6.0). These
samples were immunostained by the avidin-biotin-peroxidase
complex (ABC) method with a Vectastain ABC kit (Vector, Burlin-
game, California, USA) and mouse polyclonal antibody against
NBAS(1:150;AbnovaCorporation).Diaminobenzidinewasusedas
the chromogen. For lamin B receptor (LBR) immunostainig,
peripheral blood smears were ﬁxed at 4% paraformaldehyde for
10 min, followed by immunostaining with rabbit monoclonal
antibodyagainstLBR(1:800;ab32535;Abcam,Cambridge,UK)and
Alexa 568-conjugated goat anti-rabbit secondary antibody (1:1000;
Molecular Probes, Eugene, Oregon, USA).
RESULTS
Clinical features of a novel short stature syndrome
We enrolled 22 (64.7%) female and 12 (35.3%) male patients.
The length of gestation varied from 38 to 40 weeks (median,
39 weeks); all patients were born by normal delivery. The SDSs
of height by age from birth to 30 years is shown in ﬁgure 1. The
average SDS of height at birth was  0.9460.29 in females,
0.3160.42 in males, and  0.6560.26 in total (mean6SD).
Although the SDS of height was within 1 SDS at birth, after
1 year of age, the average SDS of height was  4.4461.19 in
females,  3.1661.06 in males, and  4.0161.29 in total
(mean6SD). The growth retardation was more severe in females
than in males (p<0.001) (ﬁgure 1). There was no statistically
signiﬁcant correlation between age and SDS (r¼ 0.76, p¼0.386)
for older than 1 year.
Theclinicalcharacteristicsof34patientsarepresentedintable1.
Ninety-seven per cent (33 cases) of the patients had normal intel-
ligence. Eighty-eight per cent of the patients had a brachycephalic
skull with hypoplasia of frontal and parietal tubers and a ﬂat
occipital area of the head (ﬁgure 2A, B and E). The patients had
a characteristic face with straight nose, prominent glabella, small
orbit, slight bilateral exophthalmos, hypoplastic cheekbone,
narrowforehead,longphiltrum,andthinlips(ﬁgure2A,B,EandF).
Figure 1 Body length standard deviation scores (SDS) by age in 34
Yakut patients with short stature with optic atrophy and PelgereHue ¨t
anomaly (SOPH) syndrome. Body length SDS were evaluated in 22 female
(open circles) and 12 male (closed triangles) patients of different ages.
Twenty-two female and 10 male patients of different ages were evaluated
more than two times. Red bars represent mean body length SDS.
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Original articleThe patients’ tissue turgor and skin elasticity were decreased in
somepatients(ﬁgure2F,GandH).Sizeoftheheadwasproportional
forthebodylength(ﬁgure2B,GandH),whereaslengthofthefour
limbswasrelativelyshortforthebodylength.Theirhandsandfeet
were small (micromelia) (ﬁgure 2C and D). Their feet were wide
and small, accompanied by a high arch and sandal chink
(about 90%). Brachydactyly was observed in all patients (100%)
(ﬁgure 2C and D). Male hypogonadism was not observed. The size
of the uterus and ovaries of the female patients was normal,
exceptinfourindividuals.Oneaffectedwomanhasasonofnormal
height.
Bone aging of the patient’s hands was delayed in 14 patients
(41.2%). Four cases in ﬁve patients examined by spinal x-ray
showedabnormalﬁndings,including:lateossiﬁcationofvertebral
apophysis (one case), dysplastic changes of spine and hypoplasia
of the 12th ribs (one case), osteochondrosis thoracic and lumbar
Table 1 Clinical features at ﬁrst diagnosis in 34 Yakut patients with short stature with optic atrophy and
PelgereHue ¨t anomaly (SOPH) syndrome
Frequency; numbers of patients who had each clinical
feature (percentage)
Sex
Total Women Men
Number of patients 22 12 34
Constitution
Normal length at birth 11 (50) 9 (75) 20 (58)
Postnatal growth failure 22 (100) 12 (100) 34 (100)
Craniofacial features
Brachycephalic skull 20 (90.9) 10 (83.3) 30 (88.2)
Hypoplasia of frontal and parietal tubers 20 (90.9) 11 (92) 31 (91.2)
Narrow forehead 20 (90.9) 11 (91.7) 31 (91.2)
Long senile face 21 (95.4) 12 (100) 33 (97.1)
Small features of face 19 (86.4) 10 (83.3) 29 (85.3)
Facial asymmetry 19 (86.4) 5 (41.7) 24 (70.6)
Straight nose with prominent glabella 19 (86.4) 12 (100) 31 (91.2)
Thick/bushy eyebrows 15 (68.2) 9 (75) 24 (70.6)
Small orbit 22 (100) 11 (91.7) 33 (97.1)
Bilateral exophthalmos 20 (90.9) 11 (91.7) 31 (91.2)
Hypertelorism 3 (13.6) 2 (16.7) 5 (14.7)
Epicanthus 16 (72.7) 6 (50) 22 (64.7)
Hypoplastic cheekbone 21 (95.4) 12 (100) 33 (97.1)
Long philtrum 19 (86.4) 9 (75.0) 28 (82.4)
Thin lips 20 (90.9) 8 (66.7) 28 (82.4)
Body and extremity features
Short neck 19 (86.4) 11 (91.7) 30 (88.2)
Loose and senile skin 22 (100) 12 (100) 34 (100)
Depressed turgor of tissue 22 (100) 12 (100) 34 (100)
Fine hair 17 (77.3) 8 (66.7) 25 (73.5)
Hypermobility of small joints 20 (90.9) 10 (83.3) 30 (88.2)
Muscular hypotonia 18 (81.8) 10 (83.3) 28 (82.4)
Micromelia 22 (100) 12 (100) 34 (100)
Brachydactyly 22 (100) 12 (100) 34 (100)
Syndactyly 1 (4.6) 1 (8.3) 2 (5.9)
Simian crease 3 (13.6) 2 (16.7) 5 (14.7)
Wide feet with high arch 19 (86.4) 11 (91.7) 30 (88.2)
Sandal chink 18 (81.8) 8 (66.7) 26 (76.5)
Wide big toe 18 (81.8) 8 (66.7) 26 (76.5)
Ophthalmological ﬁndings
Bilateral optic nerve atrophy 22 (100) 12 (100) 34 (100)
Strabismus 6 (27.2) 3 (25.0) 9 (26.5)
Pigmented nevus 1 (4.6) 1 (8.3) 2 (5.9)
Myopia 9 (40.9) 3 (25.0) 12 (35.3)
Hypermetropia 1 (4.6) 2 (16.7) 3 (8.8)
Radiological ﬁndings
Delay of chronological age 7 (31.8) 7 (58.3) 14 (41.2)
Neurological ﬁndings
Normal intellectual function 21 (95.5) 12 (100) 33 (97.1)
Pathology of other systems
High voice with harsh timber 21 (95.5) 11 (91.7) 32 (94.1)
Hypoplasia of uterus 4 (18.2) 0 4 (11.8)
Insulin dependent diabetes 2 (9.1) 0 2 (5.9)
Hypoplasia of thyroid gland 2 (9.1) 1 (8.3) 3 (8.8)
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Original articleFigure 2 Clinical features of patients with short stature with optic atrophy and PelgereHue ¨t anomaly (SOPH) syndrome. (A) 10-year-old boy with
SOPH syndrome. Note the brachycephalic skull, narrow forehead, long senile face with asymmetry, straight nose with prominent glabella, thick
eyebrows, slight bilateral exophthalmos, left external strabismus, hypoplastic cheekbone, narrow forehead, long philtrum and thin lips. (B) Woman
(33 years old) with SOPH syndrome. Note the short proportional stature, short neck, short and wide thorax, short upper and lower extremities. The
lines behind patients denote body length (cm). (C, D) Brachydactyly and small hands (C) and feet (D) of patient B. (E) 12-year-old girl with SOPH
syndrome. Note brachycephalic skull with ﬁne hair, small features of face, senile face with asymmetry, thin lips, short neck. (F, G, H) The patients’
tissue turgor and skin elasticity are decreased (arrows). (I, J) Radiograph of the thoracolumbar spine of a 21-year-old woman with SOPH syndrome
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Original articlespine (two cases) (ﬁgure 2I and J), osteoporosis (two cases)
(ﬁgure2K),anddysplastic changesinlowextremities(twocases).
Growth hormone provocation test with insulin was normal in
all examined patients (13 cases). Serum free thyroxine was
normal in all examined patients (28 cases). Brain magnetic
resonance images (MRIs) were obtained for 24 patients and
showed slight cerebellar atrophy (three cases), DandyeWalker
malformation (one case), cyst at internal capsule (one case), and
Figure 3 Ocular ﬁndings of 15-year-
old boy with short stature with optic
atrophy and PelgereHue ¨t anomaly
(SOPH) syndrome. A 15-year-old boy
(case 20) had poor vision and
photophobia. His best corrected visual
acuities were 20/40 in both eyes with
mild myopic astigmatism. (A) Fundus
photograph of the right eye. Optic disc
showed mild simple optic atrophy.
Although the macula and the peripheral
retina were normal in appearance, the
central retina was a little brownish with
arteriole narrowing around the optic
disc, suggesting nerve ﬁbre layer defect
of the retina. Arterioles were narrowed
toward the optic disc (reverse tapering),
some of which appeared to be
associated with white sheathing
(arrows). (B) Analysis by optical
coherence tomography (OCT) (Optovue,
RTVue-100, Fremont, California, USA) in
the right eye. Upper ﬁgure depicts
thickness of retinal nerve ﬁbre layer
(RNFL) along a 2 mm radius from the
centre of the optic disc measured by
OCT. (Nerve Head Map program: the
NHM4 scan). Three signiﬁcant levels,
p>5%, p< 5%, and p<1%, are
represented in green, yellow, and red as
shown in the legend box. An RNFL
defect was seen in signiﬁcantly
superior, temporal, and inferior
directions, but the nasal direction was
spared. Average thickness of the RNFL
was signiﬁcantly thin (69.31 mm,
p<p0.01). Lower ﬁgure depicts
thickness of the inner retinal layer.
Signiﬁcance of damage of the ganglion
cell complex consisting of the RNFL, the
ganglion cell layer, and the inner
plexiform layer is shown in the colour
map. Severe damage is seen around the
fovea (grey circle). Average thickness
of the ganglion cell complex is
signiﬁcantly thin (62.89 mm, p<p0.01).
Fluorescent angiography of the retina
revealed no abnormality. (C) The panel
D-15 test (Luneau, Cedex, France). The
patient revealed typical tritan colour defect. Colour vision was obviously affected. The patient could not read the Ishihara pseudoisochromatic plates.
(D) Humphrey perimetry (Carl Zeiss Meditec, Dublin, California, USA). The central 30-2 threshold program test of the right eye showed slight general
depression; mean deviation is e6.78 dB (p<0.5%) and pattern SD is 3.15 dB (normal). (E) Blue-on-yellow perimetry with the same instrument used in
E. Blue spot stimulus (1.728) with a peak transmission at 440 nm was used against a yellow background (wavelengths of 530 nm, luminance of 100
cd/m
2). The central 30-2 threshold program test of the right eye showed signiﬁcant and generalised depression; mean deviation was e19.32 dB
(p<p0.5%) and pattern SD is 4.41 dB (normal). (F) Electroretinogram (ERG) ﬁndings. Findings of the right eye are aligned in the left column to compare
with the normal pattern in the left column. Although a signiﬁcant response from rod cells (scotopic dim ﬂashes) was evident, the response from cone
cells (photopic bright ﬂashes and 30 Hz ﬂicker ERG) was severely reduced, indicating that cone cells were severely affected selectively. Oscillatory
potentials were decreased in both eyes. The ERG procedure complied with the International Society for Clinical Electrophysiology of Vision standard
protocol.
33 The recording procedures are described in a previous report.
34
shows osteochondrosis of thoracolumbar spine in lateral (I) and frontal (J) projection. (K) Radiograph of the lower extremities of a 21-year-old woman
with SOPH syndrome shows osteoporosis. (L) Blood smear shows a homozygous neutrophil for SOPH syndrome with a non-segmental (arrows) and
bilobed nucleus (dashed arrows). Scale bar indicates 10 mm.
[Continued]
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Original articleempty selae (one case). All of the examined patients (22 cases in
21 families) had a high frequency of hypolobulation of gran-
ulocyte nuclei, indicating that they had PHA (ﬁgure 2M). The
ALIs of the neutrophils were 3.7560.01 in two normal Yakut
individuals, 3.0360.35 in four carriers, and 1.5260.35 in 11
patients (mean6SD).
One of the patients’ initial symptoms was visual loss
(ﬁgures 3A, B, C, D, E and F). The onset of visual loss was
4.361.4 years of age (mean6SD; n¼34). All patients had bilateral
optic nerve atrophy (100%) and non-progressive impairment of
visual acuity (0.2360.21 (mean6SD; n¼25)). Disc paleness with
different degree of and expanded excavation was observed on
the fundi (ﬁgure 3A). Borders of the optic disc were clear, and
arteriesandveinswerenormal.Noneofthepatientshadvisualﬁeld
defect,centralscotoma,ornystagmus.Allexaminedpatients
11had
great difﬁculty reading any of the Ishihara pseudoisochromatic
plates (24 plate edition, 1964). We also performed the Farnsworth
panel D-15 test on these 11 patients and found that one patient
made a tritan error. We obtained electric sensitivity threshold and
labiality from 30 patients. The values were 245.006101.34 mkA
for electric sensitivity threshold and 25.2063.49 Hz for labiality,
indicating an impairment of functions of the retina and the optic
nerve. Myopia (12 cases), strabismus (nine cases), and hyperme-
tropia (three cases) were also observed.
Figure 4 Genotype of 30 families with
short stature with optic atrophy and
PelgereHue ¨t anomaly (SOPH)
syndrome for markers on 2p24.3.
(A) All the patients have homozygous
genotype (3/3) at D2S312.
Homozygous genotypes around
D2S312 are shaded in grey.
(B) Physical map for 2p24.3. NBAS and
DDX1 exist in the critical region deﬁned
by M1491 and M1599.
Table 2 Polymorphisms in NBAS gene identiﬁed in patients with short stature with optic atrophy and PelgereHue ¨t anomaly (SOPH) syndrome
Number of patients
Nucleotide/amino acid substitution
Exon 45 Exon 26 Exon 25 Exon 25 Exon 16 Exon 2
5741G/A/R1914H 3026G/C/C1009S 2845G/C/V949L 2775T/C/D925D 1611A/G/E537E 130C/G/E44Q
33 A C C C G G
1 A/G C/G C/G C/T G/A G/C
Minor allele frequency in normal Yakut
population (%) n¼406 chromosomes
0.49 3.37 1.43 1.9 1.9 2.4
M1542 is located between exon 16 and exon 25.
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Original articleOn the basis of these distinct clinical features, we named this
new type syndrome as short stature with optic atrophy and
PelgereHuët anomaly (SOPH) syndrome.
Identiﬁcation of the disease locus to chromosome 2p24.3
Because Yakuts are a population isolate, we applied the homo-
zygosity mapping approach.
1 5 A genome wide homozygosity
Figure 5 Haplotype of NBAS mutant
chromosome and multiple alignment of
NBAS (neuroblastoma ampliﬁed
sequence) protein. (A) Haplotype of
NBAS mutant chromosome for family
17 with short stature with optic atrophy
and PelgereHue ¨t anomaly (SOPH)
syndrome and chromatograms of the
mutation in the NBAS gene. Disease
associated haplotype is boxed. Five
nucleotide substitutions, 130C/G
(resulting in the amino acid substitution
Q44E) in exon 2; 1611A/G (not
altering the amino acid sequence) in
exon 16; 2775T/C (not altering the
amino acid sequence); 2845G/C
(resulting in the amino acid substitution
V949L) in exon 25; and 3026G/C
(resulting in the amino acid substitution
C1009S) in exon 26 in NBAS, were
observed in a patient and her father in
the homozygous state. 5741G/A
(resulting in the amino acid substitution
R1914H) in exon 45 alteration is
observed only in the patient. (B) Amino
acid sequence alignment of Homo
sapiens NBAS (GenBank accession
number NP_056993.2) with orthologs
from Pan troglodytes
(XP_001161679.1), Canis familiaris
(XP_540088.2), Gallus gallus
(XP_419959.2), and Danio rerio
(NP_001038272.1) revealed by the
ClustalW program (http://www.ebi.ac.
uk/Tools/clustalw/). Conserved amino
acid residues are shaded (GeneDoc
program, http://www.nrbsc.org/gfx/
genedoc/). Each shade represents
a degree of conservation (black, 100%;
dark grey, 80%; and grey, 60%). The
mutated amino acid R1914H was highly
conserved from human to ﬁsh, whereas
Q44E, V949L, and C1009S were less
conserved than R1914H. An amino acid
homology search was conducted using
the standard proteineprotein BLAST.
An amino acid sequence of human
NBAS (GenBank accession number
NP_056993.2), chimpanzee NBAS
(XP_001161679.1), dog NBAS
(XP_540088.2), chicken NBAS
(XP_419959.2), and ﬁsh NBAS,
(NP_001038272.1) were multiply
aligned by the ClustalW program,
version 1.83 with default parameters.
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at D2S149 in the homozygous state: the frequency of the four
allele in the normal Yakut population was 0.06 (ﬁgure 4A). Next
we conducted ﬁne genotyping using additional ﬂanking micro-
satellite markers in this region (ie, D2S168, D2S328, D2S2199,
D2S2267, D2S219, D2S312, D2S2295, D2S1360, and D2S2375).
We found that all patients had an identical allele at D2S312 in
the homozygous state (ﬁgure 4A). Loss of homozygosity was
observed distal to marker D2S219 and proximal to marker
D2S2295. Then we carried out further genotyping using micro-
satellite markers located between D2S219 and D2S2295 (ie,
M1491, M1542, and M1599); 26 patients shared the identical
haplotype 1-3-3-1 at M1491, D2S312, M1542, and M1599 in the
homozygote state. With regard to patient 817, we could not
exclude the possibility that this patient was a compound
heterozygote. Loss of homozygosity was observed distal to
marker M1491 and proximal to marker M1599 (ﬁgure 4A).
Patient AA3362 showed loss of homozygosity at M1542.
However, the patient had 1/1 genotype at M1599 that is iden-
tical to those of the other patients, suggesting that this could be
accounted for by replication slippage with the marker M1542.
Taking these ﬁndings together, we concluded that the causative
gene for SOPH is located in a 1.1 Mb segment between M1491
and M1599 (ﬁgure 4B).
Figure 6 Immunohistochemical
analysis of NBAS (neuroblastoma
ampliﬁed sequence) protein. (A) Retina
of autopsied control subject (58-year-
old man) shows expression of an NBAS
protein in the cytoplasm of ganglion
cells. The scale bar indicates 20 mm. In
the retina, the cytoplasm of retinal
ganglia cells and some of the inner layer
cells are stained with NBAS antibody
(ﬁgure 6A), whereas the outer layer
cells and an optic nerve are not stained
with NBAS antibody (ﬁgure 6B).
(B) NBAS is not expressed in cerebral
optic nerve tract from autopsied control
subject (75-year-old woman with
myositis). The scale bar indicates
200 mm. (C, D) Cytoplasm of epidermal
squamous cells are well stained with an
NBAS antibody in a subject with short
stature with optic atrophy and
PelgereHue ¨t anomaly (SOPH)
(C: 14-year-old boy) and a control (D:
50-year-old woman). The scale bar
indicates 50 mm. (E, F) Cytoplasm of
neutrophils are well stained with an
NBAS antibody in a subject with SOPH
(E: 14-year-old boy) and a control (F:
36-year-old man). The scale bar
indicates 10 mm. (G, H) Neutrophils are
well stained with a LABR antibody both
in a subject with SOPH (G: 14-year-old
boy) and a control (H: 36-year-old man).
The scale bar indicates 5 mm.
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SOPH syndrome
In the critical region, there were two genes: neuroblastoma-
ampliﬁed sequence gene (NBAS, MIM 608025) and DEAD (asp-
Glu-Ala-Asp) box polypeptide 1 (DDX1) gene (ﬁgure 4B). We
performed sequence analysis of NBAS and DDX1 in the patients
using a series of intronic primers to amplify the coding exons
and exoneintronic junctions in the NBAS and DDX1 genes. We
found no mutation in DDX1, whereas we identiﬁed six nucleo-
tide substitutions in the NBAS gene in the homozygous state in
33 of 34 patients; 130C/G (resulting in the amino acid
substitution Q44E) in exon 2; 1611A/G (not altering the
amino acid sequence) in exon 16; 2775T/C (not altering the
amino acid sequence); 2845G/C (resulting in the amino acid
substitution V949L) in exon 25; 3026G/C (resulting in the
amino acid substitution C1009S) in exon 26; and 5741G/A
(resulting in the amino acid substitution R1914H) in exon 45
(table 2). To exclude the possibility of the presence of hetero-
zygous deletions, we analysed both parents in 10 families and
found true homozygosity in all cases. Among these families, in
family 17, the unaffected father of patient 414 had ﬁve of these
six nucleotide substitutions, except 5741G/A (R1914H), in the
homozygous state (ﬁgure 5A). Furthermore, arginine at position
1914 is highly conserved among species, whereas glutamine at
position 44, valine at position 949, and cysteine at position 1009
were not conserved among species (ﬁgure 5B). Among these
substitutes, only R1914H substitution was predicted to be
possibly damaging by the Polyphen program. None of the 203
Yakut normal controls had the 5741G/A allele in the homo-
zygous state. One hundred Japanese normal controls did not
have the 5741G/A allele. Although patient 817 had these
nucleotide substitutions in the heterozygous state, we
concluded that homozygous 5741G/A substitution in the
NBAS gene associates with the SOPH syndrome.
Immunohistochemical analysis for NBAS protein
Intheretina,thecytoplasmofretinalgangliacellsandsomeofthe
inner layer cells was stained with NBAS antibody (ﬁgure 6A),
whereastheouterlayercellsandopticnervewerenotstainedwith
NBAS antibody (ﬁgure 6B). NBAS was also expressed in the
cytoplasmofsquamousepidermalcells(ﬁgure6C);theexpression
wascomparablebetweenapatientandacontrol(ﬁgure6Cand6D).
With regard to leucocytes, immunostaining for NBAS showed
comparable expression in leucocyte cytoplasm of normal individ-
uals and patients with SOPH. The autosomal dominant inherited
PHA is caused by heterozygous null mutations in the LBR gene.
18
BecausetheamountofLBRquantitativelyaffectsthelobulationof
neutrophic nuclei, we investigated expression of the LBR in
affected individuals.
18 The expression of LBR protein, however,
was comparable between normal individuals and patients
(ﬁgure 6G and H).
DISCUSSION
In this study, we have established a new disease that is a type of
short stature syndrome with autosomal recessive inheritance.
The presentation of loss of visual acuity and PHA (MIM 169400)
is unique and renders the clinical phenotype distinguishable
from other short stature syndromes, including 3-M syndrome.
The cardinal features of this syndrome are postnatal growth
retardation, small hands and feet, and loss of visual acuity and
abnormalities of colour vision. Furthermore, blood smears of
affected individuals showed PHA. In this study, we mapped the
locus for this new type of short stature syndrome to 2p24.3 and
identiﬁed an identical missense mutation in the NBAS gene.
Thirty-three of 34 patients with SOPH syndrome have
5741G/A (R1914H) substitution in the NBAS gene in the
homozygous state. The arginine at position 1914 is highly
conserved among species, and Polyphen program suggested
R1914H to be possibly damaging. None of the 203 Yakut had the
5741G/A allele in the homozygous state. None of the 100
Japanese normal controls had the 5741G/A allele. These
observations indicate that 5741G/A (R1914H) allele is associ-
ated with the SOPH syndrome. One patient had a single
5741G/A substitution in the heterozygous state. The simplest
explanation for these cases is that we failed to detect the second
mutation, which may be located in regulatory domains of the
NBAS gene that are yet to be deﬁned. Further analysis is
necessary to elucidate the disease mechanism for patient 817.
The prevalence rate of SOPH syndrome in Yakuts is 1 per
10000 (at least 33 patients among 440000 people); the carrier
frequency of the 5741G/A substitution of NBAS is approxi-
mately 1% in the Yakut population. Furthermore, all of the
affected individuals have other rare nucleotide substitutions in
NBAS: 130C/G in exon 2; 1611A/G in exon 16; 2775T/C
and 2845G/C in exon 25; and 3026G/C in exon 26. The
results indicate the Yakuts have a founder chromosome
responsible for the SOPH syndrome. We have previously
demonstrated that all Yakut patients with 3-M syndrome have
an identical mutation in CUL7.
2 Taken together, these results
strongly indicate that Yakuts are a population isolate. Because
Yakuts are the ﬁrst population isolate discovered in Asia, this
population would play an important role in identifying
a susceptibility gene for complex diseases in people with an
Asian background.
19
The NBAS gene was identiﬁed as a gene that is co-ampliﬁed
with the N-myc (MYCN) gene in neuroblastoma cell lines.
20
Northern blot analysis has revealed two alternative transcripts:
a 4.5 kb transcript encoding a deduced 1353 amino acid protein
and a 7.3 kb transcript encoding a deduced 2371 amino acid
protein.
20 21 The longer transcript, with a predicted molecular
weight of 268 kDa, is generally more abundant. NBAS
messenger RNA is highly expressed in connective tissues, eye,
brain, and spinal cord, suggesting that NBAS protein may play
an essential role in these organs (expression proﬁle is
available from NCBI: http://www.ncbi.nlm.nih.gov/UniGene/,
S.O.U.R.C.E: http://source.stanford.edu/cgi-bin/source/source-
Search). Although the function of NBAS remains unknown, it
has two putative leucine zippers, a ribosomal S14 motif and
a domain homologous to secretary pathway protein in yeast,
Sec39.
22 23 Sec39 is required for vesicle transport from the
endoplasmic reticulum (ER) to the Golgi apparatus and from the
Golgi apparatus to the ER. Indeed, recently, NBAS has been
identiﬁed as a member of a subunit of the syntaxin 18 complex,
which is associated with membrane transport; depletion
of NBAS causes redistribution of Golgi recycling proteins
accompanied by a defect in protein glycosylation, indicating
that NBAS is involved in Golgi-to-ER transport.
24 It remains
unclear why mutation of NBAS results in the narrowly
restricted clinical phenotypes in those with SOPH. NBAS might
play an important role for Golgi-to-ER or vesicle transport in the
retinal ganglion cells and affected organs. In a patient with
SOPH syndrome, the expression of NBAS was well preserved in
skin and leucocyte. Therefore the dysfunction of NBAS resulting
from the R1914H substitution may underlie the pathogenesis of
the SOPH syndrome.
Non-progressive loss of visual acuity accompanied by optic
nerve atrophy is a characteristic clinical feature in SOPH
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retina. Although we did not obtain retina from the patients
with SOPH, these ﬁndings suggest that SOPH comprises
inherited optic neuropathies that resulted from loss of retinal
ganglion cells.
25 Leber’s hereditary optic neuropathy (MIM
535000) and optic atrophy 1 (MIM 165500) are the most
frequent hereditary optic neuropathies. The function of the
causative genes for these optic neuropathies is tightly associ-
ated with mitochondrial function. Therefore, it would be
interesting to investigate the function of NBAS on mitochon-
dria in ganglion cells.
Analysis of the electroretinogram (ERG) for the individual
with SOPH syndrome revealed that the cone cell pathway was
also involved in SOPH syndrome. The visual and colour
impairment for patients with SOPH syndrome is a relatively
stationary disorder described as ‘cone dysfunction’, not
progressive cone dystrophy.
26 Most of the patients with SOPH
syndrome had complete achromatopsia (total colour blindness);
however, one of these individuals showed the blue-yellow deﬁ-
ciency (tritan). These results indicate that the homozygous state
of 5741G/A substitution in the NBAS gene does not lead only
to complete achromatopsia but can also cause incomplete
achromatopsia. Phenotype variability in cone dysfunction
syndrome has also been reported in patients with CNGA3
mutation.
27
Another characteristic ﬁnding in SOPH is PHA, which is
characterised by a hyposegmented nuclear shape and a coarse
chromatin organisation in neutrophils. PHA is characterised by
an abnormal nuclear shape in neutrophil granulocytes. The
mutation in the LBR gene, which is located at 1q42.1, has been
identiﬁed as a causative gene for PHA.
18 Although this disorder
is autosomal dominant, PelgereHuët-like cells have also been
observed in many pathological conditions (eg, myelodysplasia
and myeloproliferative disease), certain drugs, and occasional
acute infections.
28 An autosomal dominant PHA is caused by
heterozygous null mutations in the LBR gene.
18 LBR protein is
embedded within the inner nuclear membrane that interacts
with B-type lamins and nucleosomes. Although the expression
of LBR is reduced in cells with PHA,
29 we were unable to ﬁnd
a difference in LBR expression in leucocytes from patients with
SOPH syndrome. The NBAS gene is the second gene that results
in PHA and the ﬁrst gene that results in PHA in an autosomal
recessive manner. Although there are no data to suggest that
NBAS protein associates with nuclear matrix proteins, a physi-
ological role for NBAS will clarify the molecular mechanism of
PHA.
Interestingly, PHA has occasionally been described in associa-
tion with short status syndrome.
18 30 Hydropseectopic calciﬁ-
catione‘moth eaten’ (HEM)/Greenberg skeletal dysplasia, which
is an autosomal recessive chondrodystrophy with PHA, is caused
by homozygous mutations in the LBR.
31 Moreover, rabbits with
PHA homozygosity had microphthalmia and severe chon-
drodystrophy with limb defects.
32 Although the skeletal defor-
mityisnotsevereinSOPHsyndrome,theassociationbetweenthe
nuclear morphology in neutrophils and the development of the
skeletal system is interesting to indicate the molecular link
between nuclear membrane and skeletal development.
In conclusion, we have shown comprehensive clinical features
of a new type of short stature syndrome prevalent in Yakuts and
identiﬁed the missense mutation in the NBAS gene. This infor-
mation may be useful for genetic counselling in the Yakut
population. These results provide new insights for under-
standing the molecular mechanism for short stature syndromes,
optic nerve atrophy, and PHA.
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